Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Gelenis Domingo is a hematologist-oncologist at Memorial Cancer Institute.


She treats patients with a variety of cancers, including hematological malignancies (such as lymphoma and leukemia), blood benign hematology diseases, solid organ tumors (including breast, lung, prostate and colon cancer) and also cares for patients with anemia in pregnancy.

Lung Cancer Video Library Spanish - Domingo - Need of Molecular Diagnosis in Lung Cancer (NGS and PD-L1 Testing)
Lung Cancer Video Library Spanish - Domingo - NECESIDAD DE DIAGNOSTICO MOLECULAR EN CANCER DE PULMON (NGS Y pd-l1 TESTS)
Author
Gelenis Domingo, MD
Image
We are pleased to offer additions to our Lung Cancer Video Library for our Spanish speaking community.

Para estos videos adicionales a nuestra Biblioteca de videos sobre el cáncer de pulmón producidos en español para nuestra comunidad latina, la Dra. Gelenis Domingo nos brinda información actualizada. En este video, el Dr. Domingo analiza la necesidad del diagnóstico molecular en el cáncer de pulmón (pruebas NGS y PD-L1). Para unirse a la conversación, visite https://cancergrace.org/forum.

*****

For these additional videos to our Lung Cancer Video Library produced in Spanish for our Latino Community, Dr. Gelenis Domingo provides us with up to date information. In this video, Dr. Domingo discusses the need of molecular diagnosis in lung cancer (NGS and PD-L1 testing).

To join the conversation, visit https://cancergrace.org/forum.

 

 

Video Language

Next Previous link

Previous PostNext Post

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on